Reaction

Type Iii Immune Complex Mediated Reaction reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 549 reports · 7 co-occurring drugs

As of the last recalculation, Type Iii Immune Complex Mediated Reaction appears in 549 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is SIROLIMUS (PRR 46.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Sirolimus	16	46.3	46.4
Insulin Glulisine	10	38.0	38.0
Imatinib	17	37.7	37.7
Ravulizumab	13	37.3	37.4
Isoniazid	12	28.7	28.7
Pyrazinamide	7	28.6	28.6
Benralizumab	6	11.5	11.5

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.